fingolimod hydrochloride has been researched along with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, SF; Li, ZY; Little, MA; Sun, XJ; Wang, C; Wang, LY; Zhao, MH | 1 |
1 other study(ies) available for fingolimod hydrochloride and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
| Article | Year |
|---|---|
Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner.
Topics: Adolescent; Adult; Aged; Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies; Apoptosis; Female; Fingolimod Hydrochloride; Hematuria; Humans; Jurkat Cells; Kidney; Lung; Male; Middle Aged; Models, Biological; Peroxidase; Proteinuria; Rats, Inbred WKY; Signal Transduction; Sphingosine-1-Phosphate Receptors; T-Lymphocytes | 2020 |